Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T13:30:47.229Z.
Calculation as of: 2026-10-06T13:30:47.229Z.
Quote observation: 2026-10-06T13:30:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ade6551c806a0b8a23cc3b9f653dfce73cf5104c20f92b5c51aa4b81f5201f45
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$579.66M
PS Ratio
10.72
TTM Avg
11.75
3Y Avg
7.55
5Y Avg
5.31
Market Cap
$589.38M
PS Ratio
71.71
TTM Avg
55.76
3Y Avg
22.85
5Y Avg
49.57
Market Cap
$598.37M
PS Ratio
1.54
TTM Avg
1.87
3Y Avg
2.03
5Y Avg
3.14
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BlossomHill Therapeutics, Inc. (BLSM) | $583.37M | N/A | N/A | N/A | N/A |
| Aquestive Therapeutics, Inc. (AQST)vs › | $579.66M | 10.72 | 11.75 | 7.55 | 5.31 |
| CorMedix Inc. (CRMD)vs › | $578.97M | 1.25 | 2.97 | 1053.54 | 1425.81 |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $589.38M | 71.71 | 55.76 | 22.85 | 49.57 |
| OrthoPediatrics Corp. (KIDS)vs › | $595.38M | 2.36 | 1.86 | 2.98 | 5.39 |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $598.37M | 1.54 | 1.87 | 2.03 | 3.14 |
| CytomX Therapeutics, Inc. (CTMX)vs › | $568.20M | 31.05 | 14.58 | 5.61 | 4.40 |
| Immix Biopharma, Inc. (IMMX)vs › | $554.90M | N/A | N/A | N/A | N/A |
| Delcath Systems, Inc. (DCTH)vs › | $549.24M | 5.76 | 5.23 | 17.66 | 17.71 |
| Crescent Biopharma, Inc. (CBIO)vs › | $548.99M | 46.20 | 40.07 | 1866.17 | 1168.37 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
